| Date Filed | Type | Description |
| 03/06/2023 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 510 shares
@ $1.31, valued at
$668.1 |
|
| 02/08/2023 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 617 shares
@ $2.02, valued at
$1.2k
|
|
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 68,750 shares
@ $0
Granted 137,500 options to buy
@ $1.72, valued at
$236.5k
|
|
| 11/04/2019 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 40,563 options to buy
@ $2.225, valued at
$90.3k
|
|
| 03/04/2019 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Bought 3,647 shares
@ $2.81, valued at
$10.2k
|
|
| 02/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2018 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Bought 5,000 shares
@ $2.7766, valued at
$13.9k
|
|
| 11/13/2018 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Bought 5,000 shares
@ $3.1292, valued at
$15.6k
|
|
| 11/05/2018 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 40,562 options to buy
@ $2.225, valued at
$90.3k
|
|
| 09/05/2018 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 10,000 shares
@ $1.49, valued at
$14.9k
|
|
| 08/06/2018 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Bought 5,000 shares
@ $2.745, valued at
$13.7k
|
|
| 05/29/2018 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Bought 5,000 shares
@ $3.1845, valued at
$15.9k
|
|
| 01/26/2018 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 147,500 options to buy
@ $2, valued at
$295k
|
|
| 11/14/2017 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Bought 5,000 shares
@ $1.9421, valued at
$9.7k
|
|
| 09/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |